"We will introduce the 2.4 milligram pemvidutide dose in Phase III," Arbet-Engels said (Chief Medical Officer), describing PERFORMA as "an event-driven study" with "the interim analysis" at "52 weeks ...

In this guide, learn the eligibility criteria for brand-name semaglutide, cost and insurance coverage, safety risks of ...

Our cash operating expenses or combined R&D and SG&A expenses for the 2026 totaled $3.9 million compared to $2.9 million for ...

Bayer announced today that the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) and granted Priority Review designation for KERENDIA ® (finerenone), which ...

Image source: The Motley Fool. Supernus Pharmaceuticals (NASDAQ:SUPN) reported sharply higher total revenue and prescription growth, underpinned by expansion in its CNS portfolio and successful ...

Paul Jessop was found unresponsive in his flat, Prisons and Probation Ombudsman (PPO) report said ...

Scientists at the University of Maryland, Baltimore County, have uncovered a crucial trick used by enteroviruses—the group behind diseases like polio, myocarditis, encephalitis, and even the common ...

Corrie and Cold Feet star John Thomson opened up his life-changing diagnosis in a recent podcast during which he spoke out ...

High costs put tutoring out of reach for many students but jumpAgrade, a free tuition service, is changing that for some ...

Supernus Pharmaceuticals, Inc. ( SUPN) Bank of America Global Healthcare Conference 2026 May 12, 2026 6:40 PM EDT ...

It says pressure could be taken off doctors if pharmacists were allowed to treat everyday conditions, manage long-term medication and conduct skin checks.